Picture source: Osiris Therapeutics
Osiris Therapeutics (OTC: OSIR) addresses unmet medical needs in the area of wound care, orthopedics, and sports medicine utilizing regenerative medicine. The company doesn't talk much and no analyst currently covers the company, but it is quietly advancing medical science and quality of lives through innovative products. In addition, revenue growth continues and it is working on relisting on the NASDAQ. As a result, I believe this makes Osiris a valuable but not well understood company by investors.
My prior three SA articles describe Osiris' growing revenues, product lines, restoration